# Berlin Institute of Health at Charité - Universitätsmedizin Berlin

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/berlin-institute-of-health-at-charite-universitatsmedizin-berlin/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 60.6 |
| Citations | 1,762,295 |
| City | Berlin |
| Country | DE |
| Description | Berlin Institute of Health at Charité - Universitätsmedizin Berlin is a research organisation in Berlin, DE. OpenAlex records 20,468 works and 1,762,295 citations for it. 3,988 researchers list it as their most recent affiliation. |
| Homepage | https://www.bihealth.org/ |
| OpenAlex ID | https://openalex.org/I4210139777 |
| Researchers | 3,988 |
| ROR ID | https://ror.org/0493xsw21 |
| Type | facility |
| Works | 20,468 |

## University papers

Showing 12 of 28.

- [2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure](https://scholariq.org/papers/2016-esc-guidelines-for-the-diagnosis-and-treatment-of-acute-and-chronic-heart-2/)
- [How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology](https://scholariq.org/papers/how-to-diagnose-diastolic-heart-failure-a-consensus-statement-on-the-diagnosis/)
- [Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction](https://scholariq.org/papers/angiotensin-neprilysin-inhibition-in-heart-failure-with-preserved-ejection/)
- [How to diagnose heart failure with preserved ejection fraction: the HFA–PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)](https://scholariq.org/papers/how-to-diagnose-heart-failure-with-preserved-ejection-fraction-the-hfa-peff/)
- [Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction](https://scholariq.org/papers/vericiguat-in-patients-with-heart-failure-and-reduced-ejection-fraction/)
- [The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial](https://scholariq.org/papers/the-angiotensin-receptor-neprilysin-inhibitor-lcz696-in-heart-failure-with/)
- [Current State of Knowledge on Aetiology, Diagnosis, Management, and Therapy of Peripartum Cardiomyopathy: A Position Statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy](https://scholariq.org/papers/current-state-of-knowledge-on-aetiology-diagnosis-management-and-therapy-of-2/)
- [Mitochondrial function as a therapeutic target in heart failure](https://scholariq.org/papers/mitochondrial-function-as-a-therapeutic-target-in-heart-failure/)
- [Impaired Systolic Function by Strain Imaging in Heart Failure With Preserved Ejection Fraction](https://scholariq.org/papers/impaired-systolic-function-by-strain-imaging-in-heart-failure-with-preserved/)
- [2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure](https://scholariq.org/papers/2016-esc-guidelines-for-the-diagnosis-and-treatment-of-acute-and-chronic-heart/)
- [Effects of Sacubitril-Valsartan Versus Valsartan in Women Compared With Men With Heart Failure and Preserved Ejection Fraction](https://scholariq.org/papers/effects-of-sacubitril-valsartan-versus-valsartan-in-women-compared-with-men-with/)
- [Developing Therapies for Heart Failure With Preserved Ejection Fraction](https://scholariq.org/papers/developing-therapies-for-heart-failure-with-preserved-ejection-fraction/)

## University researchers

- [Elisabeth Blüthner](https://scholariq.org/researchers/elisabeth-bluthner/)

## University top topics

Showing 8 of 25.

- [COVID-19 Clinical Research Studies](https://scholariq.org/topics/covid-19-clinical-research-studies/)
- [SARS-CoV-2 and COVID-19 Research](https://scholariq.org/topics/sars-cov-2-and-covid-19-research/)
- [Cardiovascular Function and Risk Factors](https://scholariq.org/topics/cardiovascular-function-and-risk-factors/)
- [Acute Ischemic Stroke Management](https://scholariq.org/topics/acute-ischemic-stroke-management/)
- [Heart Failure Treatment and Management](https://scholariq.org/topics/heart-failure-treatment-and-management/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Single-cell and spatial transcriptomics](https://scholariq.org/topics/single-cell-and-spatial-transcriptomics/)
- [Orthopaedic implants and arthroplasty](https://scholariq.org/topics/orthopaedic-implants-and-arthroplasty/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.